Bremelanotide,formerly known as PT-141, is a peptide drug which has been under development by Palatin Technologies as a treatment for female sexual dysfunction(FSD), hemorrhagic shock, and reperfusion injury. Bremelanotide was originally tested for intranasal administration in treating FSD but this application was temporarily discontinued in 2008 after concerns were raised over increased blood pressure seen with bremelanotide administration in some patients. As of December 2014, Palatin is conducting a human phase III study using a subcutaneousdrug delivery system that appears to have little effect on blood pressure.
MF:C50H68N14O10
Other Name : bremelanotide
CAS : 189691063

Self-introduction
This is Eva from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturerspecialize in R&D the;D theD the New Drugs and Producing the Generic Medicine:

Amino Acids&Vitaminsaminsamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries.
Sincerely hope to have a chance to cooperate with you.

Peptide Categories